Similar articles

• Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.

  Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M. Jamerson KA, et al. Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003. Am J Hypertens. 2004. PMID: 15177521 Clinical Trial.
• Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.

  Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. Adigun AQ, et al. J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538. J Hum Hypertens. 2003. PMID: 12714973
• Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.

  Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B. Devereux RB, et al. Curr Med Res Opin. 2007 Feb;23(2):259-70. doi: 10.1185/030079906X162854. Curr Med Res Opin. 2007. PMID: 17288679 Clinical Trial.
• [Recent knowledge on the role of diastolic blood pressure in hypertensive patients on treatment].

  Leonetti G, Cuspidi C. Leonetti G, et al. Recenti Prog Med. 2008 Apr;99(4):191-9. Recenti Prog Med. 2008. PMID: 18595632 Review. Italian.
• Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?

  Leonetti G, Cuspidi C, Facchini M, Stramba-Badiale M. Leonetti G, et al. J Hypertens Suppl. 2000 Jul;18(3):S13-20. J Hypertens Suppl. 2000. PMID: 10952083 Review.